首页 | 本学科首页   官方微博 | 高级检索  
     


Mono-2-ethyhexyl phthalate advancing the progression of prostate cancer through activating the hedgehog pathway in LNCaP cells
Affiliation:1. WHO Collaborating Center for Research in Human Reproduction, Shanghai Institute of Planned Parenthood Research, Shanghai 200030, China;2. Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200032, China;1. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA;2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA;3. Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA;4. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA;5. Laboratory for Psychiatric Biostatistics, McLean Hospital, Belmont, MA 02478, USA;6. Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA;7. National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA;8. Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA
Abstract:Hedgehog (Hh) pathway plays a critical role in the progression of prostate cancer (PCa), the most commonly diagnosed non-cutaneous cancer in male adults. Studies showed that di-n-butyl phthalate (DBP) could interference with the Hh pathway. Di-2-ethylhexyl phthalate (DEHP), the congener of DBP, is the major plasticizer used in plastic materials that are inevitably exposed by patients with PCa. The aim of this in vitro study was to investigate whether mono-2-ethyhexyl phthalate (MEHP, the active metabolite of DEHP) could activate the Hh pathway of LNCaP cells. Results showed that the expression of the critical gene of Hh pathway PTCH and androgen-regulated gene KLK3 was significantly decreased on 3, 6 and 9 days with Hh pathway inhibitor cyclopamine's treatment. MEHP notably up-regulated the expression of PTCH with a dose–response relationship in the presence of cyclopamine, which indicate that MEHP might target on the downstream components of Hh pathway and advance the progression of PCa through activating the Hh pathway.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号